Skip to content

Biomarkers for Skin barrier and inflammation in Children with Atopic Dermatitis

Biomarkers for Skin barrier and inflammation in Children with Atopic Dermatitis - BioSCAD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40610
Enrollment
150
Registered
2014-10-06
Start date
2015-01-21
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: 100 children with atopic dermatitis, male or female, aged between 0 and 12 years, will be participating in this study.;50 children without any skin disorder or atopy (such as food allergy, allergic rhinoconjunctivitis and allergic asthma), as well as no atopy in first degree relatives, male or female, aged between 0 and 12 years, will be participating as controls

Exclusion criteria

Exclusion criteria: For Cases: No clinically skin lesion to obtain tape strips from. Use of corticosteroids or other anti-inflammatory topical treatment on the skin lesion(s) selected for tape stripping 1 week prior to the procedure. Use of emollients, soap, and cosmetics on the skin lesion(s) selected for tape stripping 48 hours prior to and during the hospital visit day. Use of oral antihistamin 1 week prior to the hospital visit day. - Onset of atopic dermatitis after the age of 2 - History of remission of atopic dermatitis without treatment (except emollients) for longer than 1 year ;For controls: history of atopy or first degree relative with atopy Use of emollients, soap, and cosmetics on the skin lesion(s) selected for tape stripping 48 hours prior to and during the hospital visit day.

Design outcomes

Primary

MeasureTime frame
Clinical and biochemical parameters in relation to the presence of AD and FLG mutations.

Secondary

MeasureTime frame
Establishment of different phenotypes of AD based on the relationschip FLG genotype and biochemical parameters

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)